CIDRAP newsletters options
The odds of myocarditis were 61% lower in flu and 85% lower in RSV than with COVID-19.
The authors call for stronger vaccination systems, interventions, and catch-up campaigns in underserved populations.
The Louisiana patient, who was exposed to sick and dead birds with suspected infection, has been hospitalized.
A leading expert, however, explains the limitations of such data and why reported prevalence of the condition can vary so widely.
Flu activity continues to elevate, and COVID-19 markers are also starting to rise from very low levels.
Five European countries have now detected poliovirus in wastewater over the past few months.
Oropouche virus activity continues its geographic expansion in the Americas region.
The buck was harvested during the opening weekend of firearms season in Deer Permit Area 271, along Minnesota's border with South Dakota.
In other developments, federal and state officials report more detections in dairy cows, poultry, and wild birds.
No COVID-19 hospitalizations occurred among vaccine recipients.
Researchers say the strain, which is resistant to 2 of the 3 antibiotics recommended for treating cholera, appears to be spreading in East Africa.
Researchers say the findings raise concerns about antibiotic resistance from inappropriate use of broad-spectrum antibiotics.
A group of 78 more samples, a variety of types, are on their way to the INRB lab in Kinshasa.
Activity continues to fluctuate across different countries, with cases of novel clade 1b continuing to rise.
Disease burden, hospitalization rates have stayed the same from 2017 to 2024.
The child tested positive for influenza A, which could indicate a range of viruses, from seasonal flu to avian flu.
Hepatitis A virus and vaccinia virus showed evidence for sexual transmission but no evidence for detection in the semen.
The study's safety board recommended halting enrollment after an assessment showed the chance was less than 1% that the study would demonstrate efficacy if completed.
The FDA says the hold is related to concerns about safety findings from a now-paused clinical trial of two RSV vaccine candidates in infants.
The declaration provides immunity for certain claims, including loss caused by or related to administration or use of countermeasures to diseases, threats, or conditions.
